BICYCLE THERAPEUTICS PLC - Ordinary Shares, nominal value GBP 0.01 per share (BCYC)
CUSIP: 088786108
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Ordinary Shares, nominal value GBP 0.01 per share
- Shares outstanding
- 50,351,032
- Total 13F shares
- 40,439,351
- Share change
- +699,612
- Total reported value
- $915,266,321
- Put/Call ratio
- 126%
- Price per share
- $22.63
- Number of holders
- 104
- Value change
- +$21,080,974
- Number of buys
- 50
- Number of sells
- 49
Quarterly Holders Quick Answers
What is CUSIP 088786108?
CUSIP 088786108 identifies BCYC - BICYCLE THERAPEUTICS PLC - Ordinary Shares, nominal value GBP 0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 088786108:
Top shareholders of BCYC - BICYCLE THERAPEUTICS PLC - Ordinary Shares, nominal value GBP 0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13F
|
Company |
19%
|
9,399,960
|
$190,255,190 | — | 30 Jun 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
6.9%
|
3,490,506
|
$70,647,841 | — | 30 Jun 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
4.5%
|
2,253,000
|
$45,600,720 | — | 30 Jun 2024 | |
| FCPM III SERVICES B.V. |
13F
|
Company |
4.2%
|
2,122,892
|
$42,967,334 | — | 30 Jun 2024 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
3.9%
|
1,972,000
|
$39,913,280 | — | 30 Jun 2024 | |
| Kate Bingham |
3/4/5
|
Director |
—
class O/S missing
|
1,870,379
|
$32,731,633 | — | 13 Jul 2021 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
3%
|
1,523,856
|
$30,842,845 | — | 30 Jun 2024 | |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD |
13F
|
Company |
3%
|
1,509,713
|
$30,556,592 | — | 30 Jun 2024 | |
| First Light Asset Management, LLC |
13F
|
Company |
2.8%
|
1,384,768
|
$28,027,704 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
2.4%
|
1,231,573
|
$24,927,037 | — | 30 Jun 2024 | |
| Fairmount Funds Management LLC |
13F
|
Company |
2.1%
|
1,069,199
|
$21,640,588 | — | 30 Jun 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
2%
|
1,004,535
|
$20,331,788 | — | 30 Jun 2024 | |
| Camber Capital Management LP |
13F
|
Company |
1.8%
|
915,000
|
$18,520,000 | — | 30 Jun 2024 | |
| EcoR1 Capital, LLC |
13F
|
Company |
1.8%
|
910,000
|
$18,418,400 | — | 30 Jun 2024 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
1.8%
|
888,081
|
$17,975,000 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.6%
|
798,501
|
$16,162,000 | — | 30 Jun 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
1.5%
|
759,180
|
$15,365,087 | — | 30 Jun 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
1.4%
|
700,000
|
$14,168,000 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.2%
|
586,622
|
$11,873,229 | — | 30 Jun 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.1%
|
572,000
|
$11,577,280 | — | 30 Jun 2024 | |
| AXA S.A. |
13F
|
Company |
1.1%
|
554,320
|
$11,219,437 | — | 30 Jun 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
1.1%
|
535,063
|
$10,829,675 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.8%
|
402,223
|
$8,140,993 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.76%
|
383,804
|
$7,768,192 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.65%
|
326,800
|
$6,614,432 | — | 30 Jun 2024 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.58%
|
293,445
|
$5,939,327 | — | 30 Jun 2024 | |
| Verition Fund Management LLC |
13F
|
Company |
0.53%
|
266,749
|
$5,399,000 | — | 30 Jun 2024 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.52%
|
264,047
|
$5,344,311 | — | 30 Jun 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.49%
|
247,814
|
$5,023,190 | — | 30 Jun 2024 | |
| PINNACLE ASSOCIATES LTD |
13F
|
Company |
0.48%
|
242,001
|
$4,898,100 | — | 30 Jun 2024 | |
| Handelsbanken Fonder AB |
13F
|
Company |
0.42%
|
213,500
|
$4,321,000 | — | 30 Jun 2024 | |
| Rubric Capital Management LP |
13F
|
Company |
0.41%
|
205,423
|
$4,157,762 | — | 30 Jun 2024 | |
| Duquesne Family Office LLC |
13F
|
Company |
0.38%
|
190,200
|
$3,850,000 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.36%
|
182,315
|
$3,690,056 | — | 30 Jun 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.31%
|
157,438
|
$3,186,545 | — | 30 Jun 2024 | |
| Aquilo Capital Management, LLC |
13F
|
Company |
0.31%
|
156,692
|
$3,171,446 | — | 30 Jun 2024 | |
| HighVista Strategies LLC |
13F
|
Company |
0.25%
|
127,255
|
$2,575,641 | — | 30 Jun 2024 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
0.25%
|
125,283
|
$2,535,728 | — | 30 Jun 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.25%
|
124,620
|
$2,522,309 | — | 30 Jun 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.24%
|
122,200
|
$2,473,328 | — | 30 Jun 2024 | |
| COMERICA BANK |
13F
|
Company |
0.22%
|
110,940
|
$2,245,426 | — | 30 Jun 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.19%
|
97,392
|
$1,971,214 | — | 30 Jun 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.19%
|
97,186
|
$1,967,045 | — | 30 Jun 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.19%
|
96,409
|
$1,951,318 | — | 30 Jun 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.18%
|
88,987
|
$1,801,097 | — | 30 Jun 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.17%
|
87,060
|
$1,762,094 | — | 30 Jun 2024 | |
| Nicholas Keen |
3/4/5
|
CHIEF SCIENTIFIC OFFICER |
—
mixed-class rows
|
125,024
mixed-class rows
|
$1,355,631 | — | 03 Jul 2024 | |
| AlphaCentric Advisors LLC |
13F
|
Company |
0.12%
|
60,000
|
$1,214,400 | — | 30 Jun 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.12%
|
58,500
|
$1,184,040 | — | 30 Jun 2024 | |
| L & S Advisors Inc |
13F
|
Company |
0.12%
|
58,335
|
$1,180,700 | — | 30 Jun 2024 |
Institutional Holders of BICYCLE THERAPEUTICS PLC - Ordinary Shares, nominal value GBP 0.01 per share (BCYC) as of Q3 2024
As of 30 Sep 2024,
BICYCLE THERAPEUTICS PLC - Ordinary Shares, nominal value GBP 0.01 per share (BCYC) was held by
104 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,439,351 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, Deep Track Capital, LP, FCPM III SERVICES B.V., RA CAPITAL MANAGEMENT, L.P., ARMISTICE CAPITAL, LLC, WESTFIELD CAPITAL MANAGEMENT CO LP, PRICE T ROWE ASSOCIATES INC /MD/, TYBOURNE CAPITAL MANAGEMENT (HK) LTD, MORGAN STANLEY, and Candriam S.C.A..
This page lists
104
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
105
Q3 2024 holders
104
Holder diff
-1
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.